Clinical trials
Blood Coagulation Disorder clinical trials
Below are recruiting blood coagulation disorder clinical trials, each written for real people, not researchers. We’re tracking 23 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06403163Recruiting
Transfusion monitoring during anesthesia
This trial looks at patients who received a drug or product to help with bleeding (hemostasis) during anesthesia. It aims to understand how these products are used and if they are safe.
AnderlechtAges Any age - NCT07164300Recruiting
Tranexamic acid dosing study in heart surgery
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
IoanninaAges 18–99 - NCT00178594Recruiting
Testing bleeding and clotting issues in people
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
Houston, TexasAges 1 day–98 years - NCT02720679Recruiting
Study genetics behind blood disorders in children and families
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
Memphis, TennesseeAges Any age - NCT03255928Recruiting
Study blood clot cell activity in people with a heart pump
This study looks at how your blood’s clot-forming cells (platelets) behave when you have a heart pump device placed (short-term or long-term). The results may help doctors better understand complications and how to manage them after implantation.
Milan, MIAges 18–75 - NCT05806346Recruiting
TXA dosing for heart surgery patients on bypass
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
SeoulAges 19 years+ - NCT01280825Recruiting
Testing how to use genetic medicine results in routine care
This study looks at how to put genetic testing results (pharmacogenomics) into regular doctor care. It aims to see whether using the results helps doctors choose safer, better-matched medications.
Chicago, IllinoisAges 18 years+ - NCT07418099Recruiting
Study on a blood test for prolonged clotting time
This study looks at a special blood test (clot waveform analysis) to see if it can help doctors better understand why some people have a prolonged clotting time. This might help them find the cause more quickly and accurately.
Leganés, MadridAges Any age - NCT07288489RecruitingPhase 3
A study on VMX-C001 for urgent surgery while on blood thinners
This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.
Chandler, ArizonaAges 18 years+ - NCT06481995RecruitingPhase 4
Factor XIII for preventing heavy bleeding after childbirth
This study tests whether giving factor XIII, a natural protein that helps blood clot, can reduce excessive bleeding after vaginal delivery. It is for women who are at least 30 weeks pregnant with a single baby and who do not have certain medical conditions.
Geneva, Canton of GenevaAges 18 years+ - NCT00230165Recruiting
Genetics and blood testing for inherited bleeding disorders
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
New York, New YorkAges Any age - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Phoenix, ArizonaAges birth–20 years - NCT05974111Recruiting
Blood and clotting tests after certain types of stroke
This hospital study looks at blood and clotting (coagulation) measurements in people who arrive with specific types of stroke or brain bleeding not caused by injury. It may help doctors better understand clotting changes after these events and improve care decisions.
GenkAges 18 years+ - NCT05645081Recruiting
Blood test study to predict stroke risk after TIA
This trial studies tiny particles in your blood (called extracellular vesicles) to understand and predict stroke risk after a TIA (a temporary stroke-like episode). It may help doctors identify who is at higher risk using blood samples, rather than only symptoms and scans.
Merthyr TydfilAges 18 years+ - NCT04524637Recruiting
Testing a clotting test in recent traumatic brain injury
This trial tests whether a special blood clotting test called thromboelastography can help assess clotting problems after a head injury. It may help doctors better understand bleeding risk and related complications early after trauma.
ShanghaiAges 18–80 - NCT05156983RecruitingPhase 3
Reversal drug for urgent surgery in people on Factor Xa blood thinners
This Phase 3 study tests TAK-330, a reversal (blocking) medicine, to reduce bleeding risk during urgent surgery for adults taking Factor Xa inhibitors like rivaroxaban, apixaban, or edoxaban. It’s for situations where surgery can’t wait and doctors need a fast way to restore normal clotting.
Arkansas City, ArkansasAges 18 years+ - NCT07012291Recruiting
Blood test for patients on blood thinners
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
Danbury, ConnecticutAges 18–80 - NCT06961175Recruiting
Platelet function study in heart surgery
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
SalamancaAges 18 years+ - NCT07104565RecruitingPhase 2
Tafasitamab for autoimmune blood cell disorders
This study tests a new drug, tafasitamab, for people with immune thrombocytopenia (ITP) or warm autoimmune hemolytic anemia (wAIHA) that has not been controlled well by other treatments. The goal is to see if it is safe and can help manage these blood cell disorders.
Glendale, ArizonaAges 18 years+ - NCT04811313Recruiting
Tranexamic acid for children having hip bone surgery
This study tests whether tranexamic acid (a medicine that helps reduce bleeding) can safely help children during certain hip bone operations. It may help lower blood loss around the surgery.
AsyutAges 1–18 - NCT07131605Recruiting
How weight-loss surgery affects heart health and inflammation
This study looks at how weight-loss surgery affects heart health by checking markers of inflammation in the blood and how blood vessels work. It may help understand why surgery lowers heart risk for people with obesity.
Cotignola, RavennaAges 18 years+ - NCT05461092RecruitingEarly Phase 1
Nerve blocks to improve pain control after spinal fusion
This early-stage study tests whether a regional nerve block can improve pain control and recovery for older adults having elective lumbar spinal fusion. If you qualify, you may receive a special pain-control injection during surgery to reduce opioid needs and improve recovery comfort.
Iowa City, IowaAges 65 years+ - NCT02579967RecruitingPhase 2
Stem cell transplant for primary immune system disorders
This study tests whether an allogeneic stem cell (bone marrow) transplant can correct an inherited immune problem in people with severe primary immunodeficiencies. It may help reduce life-threatening infections and improve quality of life, depending on your overall health and donor match.
Bethesda, MarylandAges 4–75
Hear when a new Blood Coagulation Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for blood coagulation disorder?
- Yes. Clin2 currently lists 23 recruiting blood coagulation disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a blood coagulation disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a blood coagulation disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.